Home Menu

Site Navigation



ALS News & Research For postings of news or research links and articles related to ALS

NeuroTalk Support Groups > > > >

A group of patients with terminal illnesses is urging MPs 2 give them "right to try"

 
 
Thread Tools Display Modes
Prev Previous Post   Next Post Next
Old 11-04-2016, 07:36 AM #1
MuonOne's Avatar
MuonOne MuonOne is offline
Grand Magnate
  
Join Date: Feb 2007
Posts: 3,400
15 yr Member
MuonOne MuonOne is offline
Grand Magnate
MuonOne's Avatar
 
Join Date: Feb 2007
Posts: 3,400
15 yr Member
Exclamation A group of patients with terminal illnesses is urging MPs 2 give them "right to try"
A group of patients with terminal illnesses is urging MPs to give them the “right to try” unapproved treatments.

Terminally ill patients campaign for ‘right to try’ treatments | Ottawa Citizen
MuonOne is offline   Reply With QuoteReply With Quote
 

Tags
“right, illnesses, mps, patients, urging

« Previous Thread | Next Thread »

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts
BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Similar Threads
Thread Thread Starter Forum Replies Last Post
Patients' terminal stage, incurability defined BobbyB ALS 0 04-15-2007 03:54 PM
Legislation Introduced to Ensure Coverage for Individuals with Terminal Illnesses BobbyB ALS News & Research 0 08-23-2006 10:27 AM


All times are GMT -5. The time now is 09:29 AM.


Powered by vBulletin • Copyright ©2000 - 2025, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise (Lite) - vBulletin Mods & Addons Copyright © 2025 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

All posts copyright their original authors.

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.

Always consult your doctor before trying anything you read here.

Home